Fig. 3From: Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)POPCORN study schema. NSCLC non-small cell lung cancer, i.v. intravenous, s.c. subcutaneousBack to article page